Mechanistically, RNA pull-down experiments, mass spectrometry, PathArrayTM, and RIP were used to determine that AL033381.2 binds to PRKRA and may be involved in AL033381.2-mediated oncogenic functions in HCC cells. Here, PRKRA is linked to hepatocellular carcinoma.